Hepatitis C virus prevalence among men who have sex with men: a cross-sectional study in 12 Brazilian cities
-
Published:2023-10-19
Issue:1
Volume:23
Page:
-
ISSN:1471-2334
-
Container-title:BMC Infectious Diseases
-
language:en
-
Short-container-title:BMC Infect Dis
Author:
Silva Vanessa C. M.,Kerr Lígia R. F. S.,Kendall Carl,Mota Rosa S.,Guimarães Mark Drew C.,Leal Andréa F.,Merchan-Hamann Edgar,Dourado Inês,Veras Maria Amélia,de Brito Ana Maria,Pontes Alexandre K.,Macena Raimunda H. M.,Knauth Daniela,Lima Luana N. G. C.,Cavalcante Socorro,Camillo Ana Cláudia,Díaz-Bermudez Ximena P.,Oliveira Lisangela C.,Magno Laio,Lemos Marcílio F.,Compri Adriana P.,Motta-Castro Ana Rita C.,Moreira Regina C.
Abstract
Abstract
Background
Despite the preventive policies adopted, reduction in sexually transmitted infections (STIs) among men who have sex with men (MSM) has been limited. The risk of hepatitis C virus (HCV) infection has increased among the most vulnerable population groups, including MSM. The aim of this study was to estimate the prevalence of HCV infection and to assess risky practices among MSM from 12 Brazilian cities.
Methods
This study was carried out from June to December 2016 using respondent driven sampling (RDS). Participants completed a self-administered questionnaire to collect behavioral, socioeconomic, and demographic variables. In addition, the rapid diagnostic test (RDT) for HCV was offered. Positive results were sent to Instituto Adolfo Lutz for confirmation.
Results
A total of 4,176 participants were recruited and 23 samples were sent for confirmation. Of these, 16 were confirmed, resulting in a prevalence of 0.7% (95% CI: 0.3%—1.7%). The Southeast region showed a prevalence of 0.9% (95% CI: 0.3—2.6), followed by the South region, with 0.6% (95% CI: 0.2—2.1). The Northeast region had a prevalence of 0.3% (95% CI: 0.1—1.0) and the Midwest 0.1% (95% CI: 0.0—0.7). No positive cases were found in the North. Single men aged 40 years or older were the majority of participants exposed to HCV. High levels of alcohol consumption, illicit drug use, irregular condom use, in addition to infection with other STIs, were associated with exposure to HCV.
Conclusions
STIs continue to be important health problems in Brazil and globally. Many STIs are inapparent for many years until they bring more serious consequences. Extra investment in HCV is also warranted, given that it can be eliminated. Relying solely on clinical data to provide information about inapparent infection, especially in stigmatized populations, will make that goal more difficult to achieve. Surveillance studies, such as the one reported here need to be repeated over time to demonstrate trends and to provide information for evaluation, program and policies. Investments in the most vulnerable populations are critical to achieve the World Health Organization global health goals including the elimination of viral hepatitis by 2030.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Ministério da Saúde
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Reference51 articles.
1. Polaris Observatory HCV Collaborators. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022;7(5):396–415. https://doi.org/10.1016/S2468-1253(21)00472-6.
2. Ministério da Saúde. Secretaria de Vigilância em Saúde. Manual técnico para o diagnóstico das hepatites virais. [Internet]. August 31, 2018. Available from: http://antigo.aids.gov.br/pt-br/pub/2015/manual-tecnico-para-o-diagnostico-das-hepatites-virais.
3. World Health Organization. Global hepatitis report 2017. . [Internet]. April 19, 2017. Available from: https://www.who.int/publications/i/item/9789241565455.
4. Ministério da Saúde. Secretaria de Vigilância em Saúde. Protocolo Clínico e Diretrizes Terapêuticas para Hepatite C e Coinfecções. [Internet]. March 27, 2019. Available from: https://socgastro.org.br/novo/wp-content/uploads/2021/01/protocolo_de_hepatite_c_2019.pdf.
5. Ministério da Saúde. Secretaria de Vigilância em Saúde. Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis (IST). [Internet]. August 03, 2022. Available from: https://www.gov.br/aids/pt-br/centrais-de-conteudo/pcdts/2022/ist/pcdt-ist-2022_isbn-1.pdf/view.